Doctor Anna Sina Pettersson Meyer

(Denmark)

Follow

Contributor content

Effects of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan: results from the phase 2 RESCUE-2 trial

Presentation

Effects of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan: results from the phase 2 RESCUE-2 trial

ESC 365 is supported by

novartis

Explore sponsored resources